Menu

European Measles Cases Quadrupled in 2017

The increase is attributed to a drop in immunization rates.

Feb 20, 2018
Shawna Williams

ISTOCK, ALMIR1968There were 21,315 measles cases reported across Europe in 2017, four times as many as the previous year, the World Health Organization (WHO) announced yesterday (February 19). Of the people diagnosed in Europe, 35 died of the disease, which struck hardest in Romania, Italy, and Ukraine.

“Every new person affected by measles in Europe reminds us that unvaccinated children and adults, regardless of where they live, remain at risk of catching the disease and spreading it to others who may not be able to get vaccinated,” says Zsuzsanna Jakab, WHO Regional Director for Europe, in the WHO statement. The cases and deaths “are a tragedy we simply cannot accept,” she adds.

The announcement came ahead of a meeting of health ministers to discuss how to achieve goals set out in the European Vaccine Action Plan. Those include the elimination of measles and rubella.

NBC notes that measles is highly infectious, affecting 90 percent of unvaccinated people exposed to it, and that to control the disease, 95 percent of a population must either be immunized or previously infected with the virus. In Italy, the outlet reports, vaccination rates had fallen to 85 percent in 2015.

The US Centers for Disease Control and Prevention last year warned international travelers to ensure they are vaccinated against measles.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.